Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Eukarion receives grant funds for SCS drug development

Nov. 7, 2000

Takeda's new GnRH antagonists, their production and use

Nov. 6, 2000

Kinase-inhibitory indolinone compounds patented by Sugen

Nov. 6, 2000

Novel antitumor alkaloid CWJ-a-5: pharmacokinetics in rats

Nov. 6, 2000

Idec files Zevalin BLA with FDA; European filing planned

Nov. 6, 2000

Degradation and stability of antitumor clinical candidate RH1 described at AAPS meeting

Nov. 6, 2000

Gilead begins phase II studies with liposomal formulation of lurtotecan

Nov. 6, 2000

International patent issued to DuPont for new MEK inhibitors

Nov. 3, 2000

Inhibitors of protein kinases, particularly VEGF-R2 kinase activity, described by GW

Nov. 3, 2000

Antiandrogenic antitumor agent VN/87-1 examined for pharmacokinetics in mice

Nov. 3, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...